Skip to main content

Share story

AI Infrastructure

Google releases TPU Sync to move AI context between accelerator and host memory

Google releases TPU Sync to move AI context between accelerator and host memory Image: Primary
Google released TPU Sync, an open-source library that moves stored AI context and model weights across TPU accelerator memory, host memory and networks while computation continues. Available with Python packages for PyTorch and JAX, it integrates with vLLM-TorchTPU, SGLang-TorchTPU and llm-d on Google Kubernetes Engine. The library lets serving systems reuse previously processed prompts and transfer their context between machines that process prompts and generate responses. Google reports 30% to 70% higher token output throughput for a 235B-parameter model during sustained traffic spikes, depending on traffic distribution. Those results come from internal testing under controlled laboratory conditions. Actual gains depend on workload, configuration and network bandwidth; storage tiering and reinforcement-learning transfer modules remain experimental.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Cloud Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.